These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10415006)

  • 1. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous.
    Bachmann MF; Köhler G; Ecabert B; Mak TW; Kopf M
    J Immunol; 1999 Aug; 163(3):1128-31. PubMed ID: 10415006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
    Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
    J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.
    Tivol EA; Boyd SD; McKeon S; Borriello F; Nickerson P; Strom TB; Sharpe AH
    J Immunol; 1997 Jun; 158(11):5091-4. PubMed ID: 9164923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease.
    Chikuma S; Bluestone JA
    Eur J Immunol; 2007 May; 37(5):1285-9. PubMed ID: 17429849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice.
    Hwang KW; Sweatt WB; Mashayekhi M; Palucki DA; Sattar H; Chuang E; Alegre ML
    J Immunol; 2004 Nov; 173(9):5415-24. PubMed ID: 15494488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.
    Chambers CA; Sullivan TJ; Allison JP
    Immunity; 1997 Dec; 7(6):885-95. PubMed ID: 9430233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
    Chambers CA; Kuhns MS; Egen JG; Allison JP
    Annu Rev Immunol; 2001; 19():565-94. PubMed ID: 11244047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
    Tivol EA; Borriello F; Schweitzer AN; Lynch WP; Bluestone JA; Sharpe AH
    Immunity; 1995 Nov; 3(5):541-7. PubMed ID: 7584144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: CTLA-4 on effector T cells inhibits in trans.
    Corse E; Allison JP
    J Immunol; 2012 Aug; 189(3):1123-7. PubMed ID: 22753941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CTLA-4 in regulating Th2 differentiation.
    Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
    J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
    Metz DP; Farber DL; Taylor T; Bottomly K
    J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 regulates tolerance induction and T cell differentiation in vivo.
    Walunas TL; Bluestone JA
    J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.
    Tivol EA; Gorski J
    J Immunol; 2002 Aug; 169(4):1852-8. PubMed ID: 12165509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells.
    Emoto M; Mittrücker HW; Schmits R; Mak TW; Kaufmann SH
    J Immunol; 1999 May; 162(9):5094-8. PubMed ID: 10227978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 alphabeta T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria.
    Schlotmann T; Waase I; Jülch C; Klauenberg U; Müller-Myhsok B; Dietrich M; Fleischer B; Bröker BM
    J Infect Dis; 2000 Jul; 182(1):367-70. PubMed ID: 10882627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transgenic mouse strain with antigen-specific T cells (RAG1KO/sf/OVA) demonstrates that the scurfy (sf) mutation causes a defect in T-cell tolerization.
    Zahorsky-Reeves JL; Wilkinson JE
    Comp Med; 2002 Feb; 52(1):58-62. PubMed ID: 11900414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
    Waterhouse P; Penninger JM; Timms E; Wakeham A; Shahinian A; Lee KP; Thompson CB; Griesser H; Mak TW
    Science; 1995 Nov; 270(5238):985-8. PubMed ID: 7481803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.
    Homann D; Dummer W; Wolfe T; Rodrigo E; Theofilopoulos AN; Oldstone MB; von Herrath MG
    J Virol; 2006 Jan; 80(1):270-80. PubMed ID: 16352552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.